Roche Holding AG (1ROG)
MTA
Closed
Oct 2, 2026
Day's Range
366.8052 wk Range
280.00Overview - 1ROG - Roche Holding AG
Key Statistics
Valuation
Enterprise Value
355.87B
P/E (Trailing)
‪23.60‬
Price / Sales (TTM)
‪4.86‬
Price / Book
‪8.80‬
EV / EBITDA
‪13.94‬
Profitability
Profit Margin
‪19.60%‬
Operating Margin
‪36.20%‬
Return on Assets
‪13.50%‬
Return on Equity
‪38.10%‬
Ownership
Shares Outstanding
796.76M
Float
654.08M
Held by Insiders
‪0.00%‬
Held by Institutions
‪44.21%‬
Price stats
Beta
‪0.34‬
50-Day Avg
‪383.99‬
200-Day Avg
‪369.03‬
Dividends
Payout Ratio
‪63.93%‬
Market Cap - 1ROG - Roche Holding AG
Peers - 1ROG - Roche Holding AG
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on MTA.
- 1ROGMTARoche Holding AG288.26BMarket Cap+27.18%52-week change23.60P/E (Trailing)‪19.60%‬Profit Margin
- 1LLYMTAEli Lilly and Company853.56BMarket Cap+39.59%52-week change39.07P/E (Trailing)‪33.52%‬Profit Margin
- 1JNJMTAJohnson & Johnson428.46BMarket Cap+35.10%52-week change31.33P/E (Trailing)‪21.48%‬Profit Margin
- 1ABBVMTAAbbVie Inc.344.57BMarket Cap+18.25%52-week change74.58P/E (Trailing)‪9.80%‬Profit Margin
- 1MRKXMTAMerck & Co., Inc.240.41BMarket Cap+48.40%52-week change117.34P/E (Trailing)‪4.76%‬Profit Margin
- 1NOVNMTANovartis AG Registered Shares238.75BMarket Cap+17.17%52-week change21.78P/E (Trailing)‪22.50%‬Profit Margin
- 1AMGNMTAAmgen Inc.155.67BMarket Cap+34.71%52-week change25.43P/E (Trailing)‪22.95%‬Profit Margin
Profile Summary - 1ROG - Roche Holding AG
About
Roche Holding AG is a Swiss healthcare holding company headquartered in Basel, overseeing one of the world’s largest integrated pharmaceuticals and diagnostics groups. The company operates today through two main divisions: Pharmaceuticals, which focuses on prescription medicines across oncology, immunology, infectious…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
